From: The BraveNet prospective observational study on integrative medicine treatment approaches for pain
Measure | Completers (N = 252) | Noncompleters (N = 157) | P Valueb |
---|---|---|---|
Age, y | 48.6 (15.18) | 49.8 (15.89) | .44 |
Female | 74.1% | 71.1% | .57 |
BMI (kg/m2) | 25.8 (5.49) | 25.9 (6.42) | .81 |
Duration of pain, y | 8.6 (9.34) | 6.9 (9.04) | .06 |
CES-D (0c–60) | 17.9 (10.49) | 18.3 (10.46) | .71 |
PSS-4 (0c–16) | 6.7 (3.14) | 6.4 (3.17) | .37 |
SF-12v2 mental (0–100c) | 43.5 (10.43) | 44.3 (11.17) | .47 |
SF-12v2 physical (0–100c) | 37.7 (10.24) | 36.8 (10.82) | .40 |
BPI Severity (0c–10) | 4.6 (1.86) | 4.9 (1.86) | .11 |
BPI Interference (0c–10) | 4.6 (2.58) | 4.7 (2.47) | .67 |